Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12026
PUT
Wrap Technologies
WRAP
$105M
| $23.2K | ﹤0.01% |
14,900
-22,800
| -60% | -$34.3K |
|
12027
Rail Vision
RVSN
$11.3M
| $23.1K | ﹤0.01% |
+2,370
| New | +$26.7K |
|
12028
PUT
Atossa Therapeutics
ATOS
$25.9M
| $23K | ﹤0.01% |
1,847
+907
| +96% | +$10.8K |
|
|
PVL
12029
PUT
Permianville Royalty Trust
PVL
$58.1M
| $22.9K | ﹤0.01% |
+12,400
| New | +$19.8K |
|
12030
Maison Solutions
MSS
$1.25M
| $22.9K | ﹤0.01% |
519
-287
| -36% | -$13.6K |
|
12031
PUT
DocGo
DCGO
$65.9M
| $22.9K | ﹤0.01% |
14,600
-42,800
| -75% | -$79.8K |
|
12032
Barnwell Industries
BRN
$13.9M
| $22.9K | ﹤0.01% |
+20,270
| New | +$27.6K |
|
|
VXRT
12033
CALL
DELISTED
Vaxart
VXRT
| $22.7K | ﹤0.01% |
50,300
+36,000
| +252% | +$15.7K |
|
12034
PUT
Coherus Oncology
CHRS
$185M
| $22.7K | ﹤0.01% |
31,000
-34,300
| -53% | -$29.6K |
|
12035
PUT
Cerus
CERS
$601M
| $22.6K | ﹤0.01% |
16,000
-13,800
| -46% | -$18.4K |
|
12036
CALL
ALX Oncology
ALXO
$271M
| $22.3K | ﹤0.01% |
53,800
+29,900
| +125% | +$15.1K |
|
|
CYPH
12037
Cypherpunk Technologies Inc
CYPH
$69.4M
| $22.2K | ﹤0.01% |
+74,931
| New | +$27.3K |
|
12038
GEE Group
JOB
$27M
| $22.2K | ﹤0.01% |
+112,947
| New | +$21.6K |
|
12039
Marygold Companies
MGLD
$46.3M
| $22.2K | ﹤0.01% |
28,523
-2,355
| -8% | -$2.12K |
|
12040
Entera Bio
ENTX
$500M
| $22.1K | ﹤0.01% |
+11,656
| New | +$23K |
|
12041
CALL
Cibus
CBUS
$135M
| $21.9K | ﹤0.01% |
+15,900
| New | +$32.4K |
|
12042
Rallybio
RLYB
$90.2M
| $21.9K | ﹤0.01% |
8,111
+1,510
| +23% | +$4K |
|
12043
Loop Industries
LOOP
$31.1M
| $21.9K | ﹤0.01% |
15,407
-60,529
| -80% | -$73.1K |
|
|
GGRP
12044
PUT
Glimpse Group
GGRP
$19.6M
| $21.8K | ﹤0.01% |
16,000
+5,400
| +51% | +$6.91K |
|
12045
CALL
Stereotaxis
STXS
$138M
| $21.4K | ﹤0.01% |
10,100
-8,300
| -45% | -$16.9K |
|
|
RPTX
12046
CALL
DELISTED
Repare Therapeutics
RPTX
| $21.4K | ﹤0.01% |
+15,400
| New | +$20.1K |
|
|
NOTE
12047
PUT
DELISTED
FiscalNote
NOTE
| $21.3K | ﹤0.01% |
3,317
+1,500
| +83% | +$11.2K |
|
12048
CCSC Technology International Holdings
CCTG
$10.1M
| $21.1K | ﹤0.01% |
1,971
-3,046
| -61% | -$37.7K |
|
12049
Farmmi Inc
FAMI
$4.79M
| $21.1K | ﹤0.01% |
+11,837
| New | +$20.8K |
|
|
JF
12050
J and Friends Holdings
JF
$17.4M
| $21K | ﹤0.01% |
23,495
-43,882
| -65% | -$41.9K |
|
Similar funds
Ken Griffin's Q2 2025 Portfolio in Review
As of Q2 2025, Ken Griffin held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Walmart Inc worth $401M.
- Ken Griffin's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Ken Griffin added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Ken Griffin's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Ken Griffin fully exited Kroger in Q2 2025, selling an estimated $558M.
- Ken Griffin's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Ken Griffin opened 1,459 new positions and closed 3,524 in Q2 2025.
- Ken Griffin's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.